Device / Technology News

RSS

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

5 Sep 2012

NeuroSigma's external Trigeminal Nerve Stimulation system awarded CE Certification

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that it received CE Certification for its external Trigeminal Nerve Stimulation (eTNS) system, called the Monarch, for the adjunctive treatment of epilepsy and major depressive disorder, for adults and children 9 years and older.

5 Sep 2012

BioReliance introduces Reconstructed Skin Micronucleus Assay to detect DNA damage

Sigma-Aldrich Corporation today announced that its recent acquisition, BioReliance, the biopharma and early development services business under SAFC, will introduce a new assay to detect DNA damage from products with dermal routes of exposure. The Reconstructed Skin Micronucleus (RSMN) Assay represents the first commercial offering of a Genetic Toxicology assay using three-dimensional tissue models.

5 Sep 2012

Eurofins MWG Operon acquires Illumina HiSeq 2500 and MiSeq sequencers

Eurofins MWG Operon, one of the pioneers and key providers of next generation sequencing (NGS), has added an Illumina HiSeq 2500 and an Illumina MiSeq sequencer to its fleet of NGS sequencers.

From Illumina, Inc. 5 Sep 2012

New infrared spectroscopy technique to analyze pharmacological agent-protein interactions

RUB-Researchers from the Chair for Biophysics have developed a new method for the detailed study of the interaction between pharmaceuticals and their target proteins.

5 Sep 2012

Chemotherapy increases risk for mild cognitive deficits in breast cancer patients

A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment.

5 Sep 2012

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

5 Sep 2012

S. African, S. Korean research team developing smartphone HIV testing device, application

Researchers from South Africa and South Korea are developing a smartphone-based device and application able to "photograph and analyze blood samples in areas far from laboratories to diagnose HIV and even measure the health of [patients'] immune systems," Agence France-Presse reports.

5 Sep 2012

New strategy for outsmarting cancer through its own social intelligence

In the face of mounting evidence that cancer cells communicate, cooperate and even engage in collective decision-making, biophysicists and cancer researchers at Rice University, Tel Aviv University and Johns Hopkins University are suggesting a new strategy for outsmarting cancer through its own social intelligence.

5 Sep 2012

Medivir strengthens hepatitis C platform

Medivir AB, announced today that it has acquired preclinical research stage assets from Novadex Pharmaceuticals AB. The acquisition includes intellectual property and prodrug technologies in order to further strengthen Medivir's hepatitis C platform and know how.

5 Sep 2012

Young doctors seek to alter practice of medicine; Medical schools push training in addiction

The Associated Press examines how tech-savy young doctors are changing medicine, and KHN looks at efforts to train doctors to recognize how addictions complicate other health problems.

5 Sep 2012

FDA clears Roche's automated type-specific herpes tests

Roche announced today that it has received clearance from the U.S. Food and Drug Administration for its IgG Antibody to herpes simplex virus types 1 and 2 assays for use on cobas modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection.

From Roche Sequencing and Life Science 5 Sep 2012

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Global ophthalmic company OptiMedica Corp. has announced U.S. Food and Drug Administration 510(k) market clearance of its Catalys Precision Laser System for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

5 Sep 2012

Thermal imaging technology to identify drunks

Thermal imaging technology might one day be to identify drunks before they become a nuisance in bars, airports or other public spaces. Georgia Koukiou and Vassilis Anastassopoulos of the Electronics Laboratory, at University of Patras, Greece, are developing software that can objectively determine whether a person has consumed an excessive amount of alcohol based solely on the relative temperature of different parts of the person's face.

5 Sep 2012

Exoskeleton technology now available to take home

Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.

5 Sep 2012

Eco-friendly blood glucose monitor: an interview with Gemma Evans from Cambridge Consultants

It’s not really a question of how eco-friendly or un-eco-friendly current blood glucose meters (BGMs) are compared with, say, a fridge freezer or a Boeing 747.

5 Sep 2012

Ultrastable RNA nanoparticles may help treat cancer and viral infections

A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue.

4 Sep 2012

Medical imaging not a driver of escalating Medicare costs

According to a study in the Sept. issue of the Journal of the American College of Radiology, overall non-invasive diagnostic imaging (NDI) costs to Medicare Part B dropped 21 percent from 2006 to 2010. The study reveals that medical imaging is not a driver of escalating Medicare costs.

4 Sep 2012

Study finds increase in HIV treatment use in the U.S.

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Sep 2012

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

According to a study in the Sept. issue of the Journal of the American College of Radiology, using a combination of the Internet and compact discs (CD) to transfer images during inter-hospital transfer is associated with much lower repeat imaging rates, suggesting that regional PACS networks may be useful for reducing cost and radiation exposure associated with trauma.

4 Sep 2012

Device / Technology News

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

NeuroSigma's external Trigeminal Nerve Stimulation system awarded CE Certification

BioReliance introduces Reconstructed Skin Micronucleus Assay to detect DNA damage

Eurofins MWG Operon acquires Illumina HiSeq 2500 and MiSeq sequencers

New infrared spectroscopy technique to analyze pharmacological agent-protein interactions

Chemotherapy increases risk for mild cognitive deficits in breast cancer patients

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

S. African, S. Korean research team developing smartphone HIV testing device, application

New strategy for outsmarting cancer through its own social intelligence

Medivir strengthens hepatitis C platform

Young doctors seek to alter practice of medicine; Medical schools push training in addiction

FDA clears Roche's automated type-specific herpes tests

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Thermal imaging technology to identify drunks

Exoskeleton technology now available to take home

Eco-friendly blood glucose monitor: an interview with Gemma Evans from Cambridge Consultants

Ultrastable RNA nanoparticles may help treat cancer and viral infections

Medical imaging not a driver of escalating Medicare costs

Study finds increase in HIV treatment use in the U.S.

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News